簡要描述：CRL-2095 CAL 27 人(ren)舌鱗癌細(xi)胞(bao)，ATCC 細(xi)胞(bao)|細(xi)胞(bao)系|細(xi)胞(bao)株(zhu)|細(xi)胞(bao),細(xi)胞(bao)庫管(guan)理規范，提供的細(xi)胞(bao)株(zhu)背景清楚，提供參考文獻和培養條(tiao)件(jian)。
In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Isolation:
Isolation date: 1982
Tumorigenic:
Yes
DNA Profile （STR）:
Amelogenin: X
CSF1PO: 10,12
D13S317: 10,11
D16S539: 11,12
D5S818: 11,12
D7S820: 10
THO1: 6,9.3
TPOX: 8
vWA: 14,17
CRL-2095 CAL 27 人舌鱗癌細胞
Cytogenetic Analysis:
aneuploid; modal number = 43
Age:
56 years
Gender:
male
Ethnicity:
Caucasian
Comments:
CAL 27 cells were resistant to treatment with VDS （vindesine sulfate）, CDP （cis-platinum） or ACTD （actinomycin D）.
A culture submitted to the ATCC in December 1993 was found to be contaminated with mycoplasma. Progeny were cured by a 21-day treatment with BM Cycline.
Propagation:
ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. Temperature: 37.0°C
Recommended medium （without the additional supplements or serum described under ATCC Medium）:ATCC 30-2002
recommended serum:ATCC 30-2020
References:
23521: Gioanni J, et al. Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur. J. Cancer Clin. Oncol. 24: 1445-1455, 1988. PubMed: 3181269
